N D E P logo - link to National Diabetes Education Program
National Diabetes Education Program
ndep.nih.gov campaigns
Working Together To Manage Diabetes: A guide for Pharmacy, Podiatry, Optometry, and Dental professionals
 

References

  1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. Accessed 10/16/06 at: http://www.cdc.gov/diabetes/pubs/factsheet05.htm.
  2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–32. [PMID: 12610059].[Abstract/Free Full Text]
  3. Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. Accessed 09/18/06 at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf.
  4. Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, et al. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003;6:155–64. [PMID: 12943151].[Medline]
  5. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–90. [PMID: 14532317].[Abstract/Free Full Text]
  6. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgaw MM. et al. Diabetes trends in the U.S. 1990–1998. Diabetes Care 2000;23:1278–1283.
  7. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, et al. The Spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999; 282:1519–1522.
  8. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The Continuing Epidemics of Obesity and Diabetes in the United States. JAMA, 2001; 286: 1195 –1200.
  9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. [Abstract/Free Full Text]
  10. The effect of intensive treatmentof diabetes on the development and progression of long-term complicationsin insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–86. [PMID: 8366922].[Abstract/Free Full Text]
  11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. [PMID: 9742976].[Medline]
  12. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703–13. [PMID: 9732337].[Abstract/Free Full Text]
  13. Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation. 1998;98:2513–9. [PMID: 9843456].[Abstract/Free Full Text]
  14. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253–9. [PMID: 10675071] [Medline]
  15. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766–85. [PMID: 2062512] [Medline]
  16. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1993;119:36–41. [PMID: 8498761] [Abstract/Free Full Text]
  17. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1996;276:1409–15. [PMID: 8892716] [Abstract]
  18. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ. 1998;317:720–6. [PMID: 9732339] [Abstract/Free Full Text]
  19. Schwartz JS, Boccuzzi SJ, Glick H, Cook JR, Pederson TR, Kjekshus J. Cost-effectiveness of LDL-C reduction in diabetic CHD patients: Implications from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997;96(suppl 1):1504–5. [Abstract]
  20. Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care. 1994;17:909–17. [PMID: 7956643].[Abstract]
  21. Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1992;3:S111-9. [PMID: 1457753].[Abstract]
  22. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: Quality of care in the 1990s. Ann Intern Med. 2002;136:565–74. [PMID: 11955024].[Abstract/Free Full Text]
  23. Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care. 1998;21:1432–8. [PMID: 9727887].[Abstract]
  24. Engelgau MM, Geiss LS, Manninen DL, Orians CE, Wagner EH, Friedman NM, et al. Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work Group. Diabetes Care. 1998;21:2062–8. [PMID: 9839095].[Abstract]
  25. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Herman WH. Survey of physician practice behaviors related to diabetes mellitus in the U.S. Physician adherence to consensus recommendations. Diabetes Care. 1993;16:1507–10. [PMID: 8299440].[Abstract]
  26. Ohkubo Y, et al. Diabetes Res Clin Pract. 1995; 28:103–117.
  27. American Diabetes Association Standards of Medical Care. Diabetes Care 2006; 29 (Suppl.1):S4–S42.
  28. National Diabetes Education Program. Team Care: Comprehensive Lifetime Management for Diabetes (NDEP–37). Accessed 4/06/07 at http://ndep.nih.gov/diabetes/pubs/TeamCare.pdf.
  29. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA.2002;288(19):2469–75.
  30. American Diabetes Association Position Statement on Diabetic Retinopathy. Diabetes Care. 2004;27:Suppl 1:S84–S87.
  31. Hospital discharge rates for non-traumatic lower extremity amputation by diabetes status—United States, 1997. MMWR 2001;50(43):954–8.
  32. History of foot ulcer among persons with diabetes—United States, 2000–2002. MMWR 2003;52(45):1098–1102.
  33. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contributionof depth, infection, and ischemiato risk of amputation. Diabetes Care. 1998;21(5):855–9.
  34. History of foot ulcer, op. cit.
  35. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care. 1997;20(8):1273–8.
  36. American Diabetes Association. Position Statement: Foot care in patients with diabetes mellitus. Diabetes Care. 1998;21(Suppl 1):554–5.
  37. Armstrong DG, Lavery LA, Harkless LB, op. cit.
  38. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care. 1998;21(12):2161–77.
  39. Litzelman DK, Marriot DJ, Vinicor F, op. cit.
  40. American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care (Consensus Statement). Diabetes Care. 1999;22(8):1354–60.
  41. American Diabetes Association. Clinical Practice Recommendations: Preventive foot care in people with diabetes. Diabetes Care. 2000;23(Suppl 1) 1:S55–6.
  42. National Diabetes Education Program. Feet Can Last a Lifetime: A Health Care Provider’s Guide to Preventing Diabetes Foot Problems, 2000, rev. 2001. Accessed 4/06/07 at http://ndep.nih.gov/diabetes/pubs/Feet_Kit_Eng.pdf.
  43. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics. NIH Publication No. 02-3892, revised 2002. Accessed 4/06/07 at: http://diabetes.niddk.nih.gov/dm/pubs/statistics/#7.
  44. Thomann KH, Marks ES, Adamczyk DT. Primary Eyecare in Systemic Disease, 2nd ed. New York: McGraw-Hill; 2001, p. 189–204.
  45. Diabetes Control and Complications Trial Research Group, op. cit.
  46. Chew EY, Klein ML, Murphy RP, Remaley NA, Ferris FL III, Early Treatment Diabetic Retinopathy Study Research Group: Effects of aspirin on preretinal hemorrhage in patients with diabetes mellitus. ETDRS Report Number 20. Arch Ophthalmol 113: 52–55, 1995.
  47. Early Treatment Diabetic Retinopathy Study Research Group: Effects of aspirin treatment on diabetic retinopathy. ETDRS Report Number 8. Ophthalmology 98: 757–765, 1991.
  48. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL III. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS Report Number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1992:99(9):1351–1357.
  49. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329–34.
  50. U.S. Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Dental and Craniofacial Research, 2000.
  51. Mealey BL, Oates TW. Diabetes Mellitus and Periodontal Diseases. J Periodontol 2006;77:1289–1303.
  52. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disase in the U.S. adult population. Community Dent Oral Epidemiol 2002; 30:182–92.
  53. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: Making the connection. Clinical Diabetes 2005; 23(4):171–178.
  54. Mealey, op. cit.
  55. U.S. DHHS, 2000, op. cit.
  56. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: An epidemiologic perspective. Ann Periodontol 2001;6(1):99–112.
  57. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: Two-way relationship. Ann Periodontol 1998;3(1):51–61.
  58. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG. Treatment of periodontal disease in diabetics reduces glycated hemoglobin.J Periodontol 1997;68 (8):713–9.
  59. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus.J Periodontol 1996;67(10 Suppl):1085–93.
  60. Iacopino AM. Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol 2001;6(1):125–37.
  61. Donahue RP, Wu T. Insulin resistance and periodontal disease: An epidemiologic overview of research needs and future directions. Ann Periodontol 2001;6(1):119–24.
  62. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost of illness model. J Am Pharm Assoc 2001;41:192–9.
  63. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155(18):1949–56.
  64. Bootman JL. The $76 billion wake-up call. J Am Pharm Assoc (Wash) 1996 Jan;NS36(1):27–8.
  65. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291(3):335–342.
  66. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998;8(5):1103–11.
  67. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: Hyperlipidemia. J Am Pharm Assoc, 2000;40(2):157–65.
  68. Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162(10):1149–55.
  69. Yeh G, Eisenberg D, Davis R, Phillips R, Use of complementary and alternative medicine among persons with diabetes mellitus: Results of a national survey. American Journal of Public Health, 2002: 92:1648-1652.
  70. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994;51:772–7.
  71. Hitchcock AM, Lousberg TR, Merenich J. The impact of clinical pharmacy management on cardiovascular risk reduction in patients with established heart disease in a group model health maintenance organization. Pharmacotherapy 2000;20:360–1, abstract 135.
  72. Johnson JA, Bootman JL, op. cit.
  73. Bluml BM, McKenney JM, Cziraky MJ, op. cit.
  74. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2006;29(Suppl 1):S12. http://care.diabetesjournals.org/content/vol29/suppl_1/.
  75. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2006;29(Suppl 1) http://care.diabetesjournals.org/content/vol29/suppl_1/.
  76. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2006;29(Suppl 1) http://care.diabetesjournals.org/content/vol29/suppl_1/.
  77. Ibid.
  78. Ibid.
  79. Centers for Medicare & Medicaid Services. General Program Description. Accessed 4/06/07 at: http://www.cms.hhs.gov/clia/01_overview.asp.

June 2004

 
 
     
 

NDEP logo

National Diabetes Education Program (NDEP)    http://ndep.nih.gov
NIDDK, National Institutes of Health, Bethesda, MD

A Joint Initiative of the National Institutes of Health and the
Centers for Disease Control and Prevention

  
 

NDEP Home | About Diabetes | Resources for Health, Education, and Business Professionals
Awareness Campaigns | Partnerships | About NDEP | What's New? | Contact Us | Site Map

DHHS Home | NIH Home | NIDDK Home | CDC Home
Search NIDDK | Privacy Statement | Disclaimers